.
Pharmacoeconomics
Study Course Description
Course Description Statuss:Approved
Course Description Version:5.00
Study Course Accepted:21.03.2024 09:29:47
| Study Course Information | |||||||||
| Course Code: | VVDG_027 | LQF level: | Level 7 | ||||||
| Credit Points: | 2.00 | ECTS: | 3.00 | ||||||
| Branch of Science: | Economics; Other economic and management sub-sectors | Target Audience: | Clinical Pharmacy | ||||||
| Study Course Supervisor | |||||||||
| Course Supervisor: | Daiga Behmane | ||||||||
| Study Course Implementer | |||||||||
| Structural Unit: | Faculty of Social Sciences | ||||||||
| The Head of Structural Unit: | |||||||||
| Contacts: | Dzirciema street 16, Rīga, szf rsu[pnkts]lv | ||||||||
| Study Course Planning | |||||||||
| Full-Time - Semester No.1 | |||||||||
| Lectures (count) | 6 | Lecture Length (academic hours) | 2 | Total Contact Hours of Lectures | 12 | ||||
| Classes (count) | 6 | Class Length (academic hours) | 2 | Total Contact Hours of Classes | 12 | ||||
| Total Contact Hours | 24 | ||||||||
| Study course description | |||||||||
| Preliminary Knowledge: | Basics of Economics (desirable). | ||||||||
| Objective: | To learn the theoretical basis of pharmacoeconomics and the practical application of its methods for the economic analysis of medicinal products and the choice of cost-effective and evidence-based drug therapy. To promote students' understanding of basic public health issues and solutions to reduce the economic burden caused by the disease, as well as to promote the development of students' scientific, critical, systematic and analytical thinking. | ||||||||
| Topic Layout (Full-Time) | |||||||||
| No. | Topic | Type of Implementation | Number | Venue | |||||
| 1 | Principles and methods of economic evaluation of pharmaceuticals | Lectures | 1.00 | auditorium | |||||
| 2 | Principles of decision making in health care | Classes | 1.00 | auditorium | |||||
| 3 | Clinical effectiveness of pharmaceuticals | Lectures | 1.00 | auditorium | |||||
| 4 | Analysis of clinical trials of pharmaceuticals | Classes | 1.00 | auditorium | |||||
| 5 | Classification of health care and pharmaceutical costs | Lectures | 1.00 | auditorium | |||||
| 6 | Identification, evaluation and analysis of pharmaceutical costs | Classes | 1.00 | auditorium | |||||
| 7 | Methods of pharmacoeconomic analysis | Lectures | 1.00 | auditorium | |||||
| 8 | Quality of life assessment | Lectures | 1.00 | auditorium | |||||
| 9 | Evaluating the cost-effectiveness of pharmaceuticals | Classes | 2.00 | auditorium | |||||
| 10 | Economic modelling | Lectures | 1.00 | auditorium | |||||
| Classes | 1.00 | auditorium | |||||||
| Assessment | |||||||||
| Unaided Work: | The student independently learns and searches the literature suggested, performs basic evaluation and analysis of data, prepares a comparison of different types of medicinal therapy, performs clinical and economic evaluation, calculates the cost-effectiveness indicators of pharmaceuticals | ||||||||
| Assessment Criteria: | 20% independent work during classes 80% defence and presentation of individual assignment | ||||||||
| Final Examination (Full-Time): | Exam (Written) | ||||||||
| Final Examination (Part-Time): | |||||||||
| Learning Outcomes | |||||||||
| Knowledge: | • The essence and application of pharmacoeconomics. • Methods of economic analysis. • Opportunities, advantages and disadvantages ofclinical trial data • Clinical efficacy of medicines. • Cost categories and breakdown. • The concept of cost-effectiveness of pharmaceuticals and calculation methods. • Principles and application of economic modeling. | ||||||||
| Skills: | • Apply the methods of pharmacoeconomics. • Critically assess the publications of clinical trials of pharmaceuticals. • Assess the level of evidence for decisions on the choice of alternative treatments. • Assess and calculate the costs of medicinal therapy. • Select the appropriate method of pharmacoeconomics. • Calculate and assess the cost-effectiveness of pharmaceuticals. | ||||||||
| Competencies: | • Develop rational pharmacotherapy-based health policy • Identify the objectives of drug policy both at system and medical institution level • Determine rational and cost-effective pharmaceutical prescribing and consumption principles • Promote the provision of cost-effective health care services | ||||||||
| Bibliography | |||||||||
| No. | Reference | ||||||||
| Required Reading | |||||||||
| 1 | Drummond M. (2015) Methods for the Economic Evaluation iof Health Care Programmes, Oxford University Press | ||||||||
| 2 | PharmacoEconomics. (Online) | ||||||||
| 3 | Sorenson C, et al (2008) Ensuring Value for Money: The Role of Health Technology Assessment in the European Union. European Observatory. (akceptējams izdevums) | ||||||||
